Evidence Synthesis & Indirect Comparisons Vendors
Compare HEOR partners for systematic literature reviews, network meta-analyses and indirect treatment comparisons for HTA and value submissions.
Related workflows
Agency · +3 more types
Costello Medical is an employee-owned consultancy for literature reviews, economic models, HTA submissions, real-world evidence and medical communications.
Evidence-backed capability match
“Implementing meta-analysis, network meta-analysis (NMA) and indirect treatment comparison (ITC) methods, including (but not limited to) matching-adjusted indirect comparison…”Source: costellomedical.com
Also offers: HTA Strategy & Submissions, Health Economic Modeling, +2 more
Agency · +3 more types
Oxford PharmaGenesis is a HealthScience communications consultancy providing publications, medical writing, HEOR, HTA and market access services.
Evidence-backed capability match
“Our technical experts and trusted partners advise on the optimal approach for meta-analysis and indirect treatment comparison, developing HTA-compliant feasibility analyses…”Source: pharmagenesis.com
Also offers: Publication Planning & Management, Medical Communications Writing, +2 more
Consulting / Advisory Firm · +2 more types
OPEN Health is a consulting and agency partner providing HTA strategy and submissions, RWE for HEOR, and scientific communications services.
Evidence-backed capability match
“AI-enabled systematic reviews deliver structured, citation-ready evidence faster. Experts validate every step.”Source: openhealthgroup.com
Also offers: HTA Strategy & Submissions, RWE for Access & HEOR, +3 more
Agency · +3 more types
Precision AQ is a life sciences agency for market access and HEOR strategy, KOL engagement and scientific communications.
Products: AccessGenius, AccessGenius Insights +9 more
Evidence-backed capability match
“We leverage state-of-the-art evidence synthesis techniques—network meta-analyses, population-adjusted indirect comparisons, external controls, validation of surrogate endpoints…”Source: precisionaq.com
Also offers: Market Access Strategy & Launch Planning, Key Opinion Leader (KOL) & Stakeholder Engagement, +3 more
Software / Technology Platform · +4 more types
Axtria is a life sciences software and analytics provider for sales operations, commercial analytics, and real-world evidence.
Products: Axtria SalesIQ, Axtria MarketingIQ +7 more
Evidence-backed capability match
“By combining systematic literature review, real-world evidence analysis, and economic modeling, Axtria helped identify key patient segments, quantify disease burden, and…”Source: axtria.com
Also offers: Commercial Performance Measurement, Territory Alignment & Roster Management, +4 more
CRO / Research Services Provider · +7 more types
IQVIA is a CRO and technology provider delivering clinical trials, real-world evidence, commercial intelligence and safety operations.
Products: IQVIA Vigilance Platform, SmartSolve +4 more
Evidence-backed capability match
“Partner with IQVIA to conduct best-in-class indirect treatment comparison programs”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
Service Provider · +3 more types
Trinity Life Sciences is a commercialization intelligence partner offering market access strategy, launch strategy, forecasting and market research.
Products: TrinityEDGE, InsightsEDGE +6 more
Evidence-backed capability match
“Develop robust evidence-generation roadmaps and execute key HEOR initiatives, including literature reviews, dossiers, burden of illness studies, and stakeholder research.”Source: trinitylifesciences.com
Also offers: Market Research & Primary Insights, Product Launch Strategy & Readiness, +2 more
Consulting / Advisory Firm · +2 more types
Voisin Consulting Life Sciences provides regulatory, clinical, pharmacovigilance, market access and development services.
Evidence-backed capability match
“Conducting systematic literature reviews, indirect comparisons, and network meta-analyses, integrating potential PICOs”Source: voisinconsulting.com
Also offers: Regulatory Development Strategy & Agency Interactions, Market Access Strategy & Launch Planning, +3 more
Consulting / Advisory Firm · +4 more types
Lumanity is a life sciences consultancy for market access strategy, health economic modeling, brand positioning and scientific communications.
Products: Lumanity Illuminator, Evidence Illuminator +9 more
Evidence-backed capability match
“…Indirect treatment comparisons (ITCs)”Source: lumanity.com
Also offers: Market Access Strategy & Launch Planning, Brand Strategy & Positioning, +2 more
Compare listed vendors
What this covers: Evidence review and comparative-effectiveness methods used for HEOR, HTA, reimbursement, and value submissions.
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Axtria | Software / Technology Platform | Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “By combining systematic literature review, real-world evidence analysis, and economic modeling, Axtria helped identify key patient segments, quantify disease…”axtria.com · reviewed Oct 26, 2026 |
| Costello Medical | Agency | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “Implementing meta-analysis, network meta-analysis (NMA) and indirect treatment comparison (ITC) methods, including (but not limited to) matching-adjusted…”costellomedical.com · reviewed Oct 21, 2026 |
| IQVIA | CRO / Research Services Provider | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “Partner with IQVIA to conduct best-in-class indirect treatment comparison programs”iqvia.com · reviewed Oct 20, 2026 |
| Lumanity | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “…Indirect treatment comparisons (ITCs)”lumanity.com · reviewed Oct 21, 2026 |
| OPEN Health | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “AI-enabled systematic reviews deliver structured, citation-ready evidence faster. Experts validate every step.”openhealthgroup.com · reviewed Oct 20, 2026 |
| Oxford PharmaGenesis | Agency | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “Our technical experts and trusted partners advise on the optimal approach for meta-analysis and indirect treatment comparison, developing HTA-compliant…”pharmagenesis.com · reviewed Oct 20, 2026 |
| Precision AQ | Agency | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “We leverage state-of-the-art evidence synthesis techniques—network meta-analyses, population-adjusted indirect comparisons, external controls, validation of…”precisionaq.com · reviewed Oct 25, 2026 |
| Trinity Life Sciences | Service Provider | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “Develop robust evidence-generation roadmaps and execute key HEOR initiatives, including literature reviews, dossiers, burden of illness studies, and…”trinitylifesciences.com · reviewed Oct 21, 2026 |
| Voisin Consulting Life Sciences | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, HTA Strategy & Submissions, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “Conducting systematic literature reviews, indirect comparisons, and network meta-analyses, integrating potential PICOs”voisinconsulting.com · reviewed Oct 20, 2026 |